Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18841250 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Eflornithine Plus Sulindac in Preventing Colorectal Cancer in Patients With Benign Colorectal Polyps
Condition: Colorectal Cancer
Intervention: Drug: eflornithine plus sulindac

Indicates status has not been verified in more than two years